Speaker illustration

Doctor Nikita Ermolaev

Medical University of Vienna, Vienna (Austria)

Member of:

European Society of Cardiology

Potential hematopoietic effects of SGLT2 inhibitors in patients with cardiac amyloidosis.

Event: ESC Congress 2024

Topic: Cardiovascular Disease in the Elderly

Session: Primary care for the elderly patient: practical aspects

Thumbnail

Cardiopulmonary exercise testing in correlation with magnetic resonance imaging in patients with cardiac amyloidosis

Event: ESC Preventive Cardiology 2024

Topic: Spiroergometry

Session: The power of exercise testing for cardiovascular risk assessment

Thumbnail